Fundraising Fox

Deep Tech Startups

5,913 companies tagged Deep Tech, with their investors and founders.

Enspired Solutions

Enspired Solutions offers PFAS destruction technology for water, providing services including benchtop treatability studies, feasibility study support, field pilot tests, and full-scale on-site implementation. It serves clients needing to confirm technology compatibility and destroy PFAS contaminants in water.

2 investors

Entalpic

Entalpic uses AI and atomistic simulations to design molecules and materials for industrial surface chemistry processes, combining machine learning with quantum simulations and experimental feedback loops to accelerate materials discovery.

2 investors

ENVGO Inc.

ENVGO builds electric-propulsion marine technology that lifts vessels above the water to improve efficiency and adds autonomy, real-time awareness, and safety systems for defence, transportation, and recreational markets. The Canada-based company applies aerospace, robotics, AI, and EV engineering to boats.

2 investors

EPIC Micro

EPIC Microsystems designs compact, efficient power delivery solutions for AI servers using hybrid-switched-capacitor (HSC) architectures to enable high power density racks. It targets data center and AI server hardware customers, addressing scalability, size, thermals, and efficiency in power delivery for AI processors.

2 investors

Epicsbiotech

EPICS is a biotech company developing plant biology and protein engineering technology to produce agricultural inputs such as crop protection products and biostimulants. It applies plant molecular farming and epigenetics research to create scalable expression systems for high-value protein production in agriculture.

2 investors

Epigenica

Epigenica develops products for epigenetic analysis, including its EpiFinder platform, a multiplexed ChIP-seq technology built on patented hmqChIP-seq for high-throughput profiling of epigenetic marks such as DNA methylation and histone modifications. Its tools target researchers studying epigenetic biomarkers to support human health research.

2 investors

Epigenictx

Epigenic Therapeutics develops epigenetic medicines using an Epigenetic Modulator platform that combines nuclease-inactivated dead Cas proteins with epi-enzymes to control gene expression without cutting or altering DNA. The company applies this technology to treat hard-to-treat diseases, including chronic Hepatitis B, and delivers its therapies via proprietary LNP formulations.

2 investors

Epyr

Epyr develops thermal energy storage solutions for industrial heat electrification, enabling industries to decarbonize and adopt renewable energy. The company serves industrial customers seeking to reduce carbon emissions through practical, scalable electrification.

2 investors

equal1

Equal1 builds rack-mounted quantum computers (RacQ) using silicon CMOS-based quantum processors (UnityQ) that run alongside existing CPU and GPU compute in standard data center racks. Its systems target hybrid quantum, classical and AI workloads such as molecular simulation, optimization, quantum AI training, and Monte Carlo risk and pricing models.

2 investors

Equatorial Space Systems Pte Ltd

Equatorial Space develops modular, low-cost space launch vehicles powered by proprietary hybrid rocket engine technology using HTP and HRF-1 propellant. The company offers VOLANS for orbital payload delivery (up to 750 kg) and DORADO for suborbital launches, both designed to be explosives-free with reduced environmental impact.

2 investors

Erisyon

Erisyon develops a single-molecule protein sequencer using its Fluorosequencing technology, applying next-generation DNA sequencing approaches to proteomics. The platform is aimed at protein analysis and disease detection for biological research and medical applications.

2 investors

Esperovax

Esperovax is a biotechnology company developing an oral mRNA-based vaccine and biotherapeutic platform that produces shelf-stable vaccines in tablet and capsule form as an alternative to injection-based treatments. Its technology uses genetically modified probiotics and yeast-based virus-like particle secretion to deliver therapeutics for treatable diseases.

2 investors

Esphera SynBio Inc.

Esphera designs transgenes that enable budding exosomes to carry multimeric proteins for therapeutic applications, with initial focus on modifying tumor-derived exosomes to create immunostimulatory cancer vaccines.

2 investors

Estat

ESTAT develops electroadhesive actuator technology for robotics and physical AI systems, offering a magnet-free alternative to conventional actuators that is thinner, lighter, and more energy-efficient. The technology relies on a US-based supply chain and targets robotics hardware applications.

2 investors

Ethereal

EtherealX (referred to as "The Guild") is developing Razor Crest Mk 1, a fully reusable medium-lift orbital launch vehicle designed to lower launch costs and support multi-customer, multi-payload missions with up to 16 orbit insertions per flight. The company operates what it describes as India's largest privately-owned rocket testing facility.

2 investors

EuQlid

EuQlid builds magnetic imaging technology that uses quantum defects in diamond to non-invasively map buried electrical currents and identify connectivity defects in materials and devices. Its Quantum Diamond Microscope serves semiconductor advanced packaging, silicon 3D architectures, and energy storage/battery applications for metrology and defect analysis.

2 investors

EurekaBio

EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions. The company positions itself as a provider of comprehensive, research-driven solutions to CGT challenges.

2 investors

Events

Pivot is an AI operating system for procurement that manages the complete procurement lifecycle in a single platform, built on a modern data layer with real-time ERP connections and AI agents for tasks such as benchmarking, intake requests, and negotiations. It serves enterprises, including high-growth tech companies and Fortune 500 firms, across finance and procurement functions.

2 investors

Eventual

Eventual develops data infrastructure for teams building physical AI, particularly focused on handling video and sensor data at scale. Their product MultiBase enables semantic indexing and querying of fleet perception data to optimize model training and GPU efficiency.

2 investors

Everspin

Everspin develops and manufactures MRAM (magnetoresistive RAM) persistent memory products, including its PERSYST STT-MRAM families for data centers, enterprise, industrial, and embedded systems. Its non-volatile memory serves critical systems across aerospace and defense, AI, automotive, gaming, medical, industrial, and smart energy applications.

2 investors

Everstar

Everstar develops AI systems for the nuclear energy industry, covering engineering, licensing, qualification, workforce training, manufacturing, construction, and plant operations to speed reactor deployment. Its products include Gordian, an AI backbone for nuclear work, and Titan, a manufacturing effort aimed at building 400 GW of nuclear capacity in America by 2050.

2 investors

EvodiaBio

Evodia is a Danish aroma company that uses precision fermentation with proprietary yeast strains to produce monoterpenes, the natural molecules behind flavor and aroma, as a sustainable alternative to plant-derived ingredients. Its Yops product provides customizable aroma blends for brewers, positioned as an alternative to hops in non-alcoholic and alcohol-free beer.

2 investors

Evozyne

Evozyne is an AI-native biotech that designs de novo therapeutic proteins using EvoGen, a machine learning engine, and EvoLab, a high-throughput experimental facility that synthesizes and tests candidate proteins. It focuses on immunology, advancing a pipeline of engineered proteins such as IgG proteases, next-generation cytokines, and respiratory disease candidates toward clinical evaluation.

2 investors

Exeliom Biosciences

Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis). The company's projects have been supported by public and non-profit funding programs.

2 investors

Other sectors & tags